Pain Bloc maker granted new patent for capsaicin formulations
The Patent and Trademark Office has issued a new patent to Vizuri Health Sciences, granting the Fairfax, Va.-based company exclusive rights to certain high-strength topical capsaicin compositions.
The company said the new patent protects its PainBloc24 OTC product, as well as two products currently being developed to relieve osteoarthritic knee pain.
“We are gratified that the U.S. Patent and Trademark Office has recognized the utility and advantages of our unique capsaicin-containing formulations by granting us this important patent,” Vizuri president and CEO William Moore said. “The patent improves our ability to develop, market and protect highly safe, effective, and nonaddictive products for the treatment of numerous chronic pain conditions that affect our aging demographic, and further establishes our competitive position in the marketplace.”
The company said the new patent protects its PainBloc24 OTC product, as well as two products currently being developed to relieve osteoarthritic knee pain.
“We are gratified that the U.S. Patent and Trademark Office has recognized the utility and advantages of our unique capsaicin-containing formulations by granting us this important patent,” Vizuri president and CEO William Moore said. “The patent improves our ability to develop, market and protect highly safe, effective, and nonaddictive products for the treatment of numerous chronic pain conditions that affect our aging demographic, and further establishes our competitive position in the marketplace.”